Clinical Trial Update: Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated lofexidine for treatment of opioid withdrawal and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Substance Use Disorder

Drugs mentioned

• LOFEXIDINE (LOFEXIDINE)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 1 | Status: COMPLETED